We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
1751
DELISTED
R1 RCM Inc. Common Stock
RCM
| $6.27M | ﹤0.01% |
572,449
-48,731
| -8% | -$619K |
|
1752
J&J Snack Foods
JJSF
$1.71B
| $6.26M | ﹤0.01% |
41,809
-2,064
| -5% | -$306K |
|
|
LBAI
1753
DELISTED
Lakeland Bancorp Inc
LBAI
| $6.25M | ﹤0.01% |
355,071
-32,894
| -8% | -$587K |
|
1754
Target Hospitality
TH
$1.64B
| $6.24M | ﹤0.01% |
412,463
+169,561
| +70% | +$2.28M |
|
1755
Health Catalyst
HCAT
$128M
| $6.24M | ﹤0.01% |
587,180
+61,488
| +12% | +$594K |
|
1756
Marcus & Millichap
MMI
$1.19B
| $6.22M | ﹤0.01% |
180,620
-247,105
| -58% | -$8.77M |
|
|
MDC
1757
DELISTED
M.D.C. Holdings, Inc.
MDC
| $6.22M | ﹤0.01% |
196,769
-21,422
| -10% | -$662K |
|
|
JBGS
1758
JBG SMITH
JBGS
$708M
| $6.21M | ﹤0.01% |
327,040
-14,608
| -4% | -$282K |
|
1759
Stoneridge
SRI
$213M
| $6.19M | ﹤0.01% |
287,193
-42,597
| -13% | -$912K |
|
1760
Cinemark Holdings
CNK
$4.32B
| $6.19M | ﹤0.01% |
714,606
-14,547
| -2% | -$164K |
|
1761
G-III Apparel Group
GIII
$1.5B
| $6.18M | ﹤0.01% |
450,756
+124,024
| +38% | +$2.09M |
|
1762
Alkami Technology
ALKT
$2.11B
| $6.18M | ﹤0.01% |
423,301
-19,227
| -4% | -$268K |
|
1763
InterDigital
IDCC
$8.89B
| $6.17M | ﹤0.01% |
124,709
-11,085
| -8% | -$541K |
|
1764
Adaptive Biotechnologies
ADPT
$3.97B
| $6.16M | ﹤0.01% |
806,793
+359,342
| +80% | +$2.8M |
|
1765
The GEO Group
GEO
$4.04B
| $6.16M | ﹤0.01% |
562,300
+159,727
| +40% | +$1.55M |
|
1766
PubMatic
PUBM
$810M
| $6.15M | ﹤0.01% |
480,092
-7,019
| -1% | -$110K |
|
1767
Treace Medical Concepts
TMCI
$309M
| $6.13M | ﹤0.01% |
266,499
+138,865
| +109% | +$3.2M |
|
1768
Editas Medicine
EDIT
$442M
| $6.12M | ﹤0.01% |
690,291
+106,544
| +18% | +$1.17M |
|
1769
Q2 Holdings
QTWO
$3.92B
| $6.08M | ﹤0.01% |
226,422
-56,837
| -20% | -$1.59M |
|
1770
WD-40
WDFC
$3.15B
| $6.08M | ﹤0.01% |
37,734
-1,873
| -5% | -$312K |
|
1771
Cracker Barrel
CBRL
$1.29B
| $6.08M | ﹤0.01% |
64,122
-6,597
| -9% | -$687K |
|
1772
Bank of Hawaii
BOH
$3.13B
| $6.06M | ﹤0.01% |
78,142
-1,728
| -2% | -$134K |
|
1773
Stratasys
SSYS
$774M
| $6.06M | ﹤0.01% |
510,821
-1,193,141
| -70% | -$15.9M |
|
1774
Brady Corp
BRC
$4.57B
| $6.05M | ﹤0.01% |
128,443
-28,740
| -18% | -$1.32M |
|
|
TBI
1775
Trueblue
TBI
$311M
| $6.04M | ﹤0.01% |
308,226
-64,563
| -17% | -$1.31M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.